Introduction
T h e integrity of the animal cell membrane is believed to be maintained in part by the large (approx. 400 kDa) cytoskeletal proteins dystrophin and utrophin. Both proteins are capable of forming a link, probably flexible and potentially extensible/compressible, between the actin cytoskeleton and the cell membrane itself. Utrophin is expressed in all cell types, whereas dystrophin expression is restricted to muscle and tissues of neuronal origin. Mutations in these genes, utrophin on human chromosome 6 and dystrophin on the X chromosome, would be expected to have severe consequences for the cell. Mutations in the dystrophin gene are known, giving rise to the Duchenne and Becker muscular dystrophy phenotypes (DMD and BMD respectively). Mutations that lead to the functional absence of dystrophin protein -promoter defects, premature stop codons and other missense mutationsgenerally present as the more common and severe DMD phenotype. Deletions, truncations and substitutions that maintain the reading frame of the DNA and allow the expression of altered dystrophin protein generally lead to the milder but less common BMD phenotype. These rarer mutations are therefore much more informative in ascribing functional importance to the dystrophin protein, as disease severity can be correlated with the position of any mutations in the protein. Despite the correspondingly large size of the utrophin gene, no mutations in utrophin have yet been found, leading to the suggestion that the protein is essential for life. An understanding of the functions of the various regions of the dystrophin protein and its close relative, utrophin, will provide useful information regarding the potential use of utrophin in gene therapy approaches in DMD and BMD.
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each possesses an N-terminal F-actin-binding domain, a series of triple-helical coiled-coil repeats making up approx. 75% of each protein and a C-terminal region comprising several domains involved in protein-protein interactions and possibly signalling functions. In-frame deletions in the central triple-helical coiled-coil regions, by far the most common, present with the mildest BMD phenotypes, whereas mutations in the N-terminal region present with severe BMD and mutations in the C-terminal region lead to DMD. On this basis it can be seen that the regions in dystrophin that form the connections to the actin cytoskeleton and to the membrane are the most important, with the central (spacer/flexible) region to some extent being redundant. The present paper will therefore concentrate on recent structural and functional analysis of the N-and C-terminal domains, with details of the central coiled-coil region presented elsewhere [ 1, 2] . nine for serine within ABS2 has a profound (platelet) F-actin were determined in saturation sedimentation Feffect on the stoichiometry of binding without actin-binding assays as described previously [3] . UTR261 is the cleaved product of a glutathione S-transferase fusion construct containing a threonine for serine substitution at residue I 13:
unlikely. Thus, despite the (approx. two-UTR261 + is a non-fusion product of wild-type sequence. Afinfold) difference in affinity for F-actin, the actinities are in pM fS.E.M.; ND, not determined. affecting affinity' this binding domains of dystrophin and utrophin can be considered to be functionally equivalent, in as much as they simply bind to F-actin and do not cap, cross-link or sever actin filaments or affect actin polymerization kinetics. The affinities of dystrophin and utrophin actin-binding domains for F-actin are shown in Table 1 . One difference between the actin-binding domains of dystrophin and utrnphin is in their interaction with calmodulin. Whereas calmodulin binds to both expressed actin-binding domains in the presence of calcium but not in its absence [6, 7] , only the binding of utrophin to F-actin is affected by cal- 
Binding of UTR26 I + to F-actin
Binding curve for bacterially expressed utrophin residues 1-26 I , wild-type sequence (UTR261 +), in the presence of 10 pM Factin (mean of two separate experiments). F-actin sedimentation assays were performed as previously described and quantified by densitometric analysis of SDS/polyacrylamide gels [3] , Inset: parameters from curve fitting. UTR261 + bound to F-actin with an apparent stoichiometry of I , I (ml) and affinity of I9 f 2 p M (m2). MO is a function of x ; Chisq, chi squared; R is the regression fit of the data to the calculated line; NA. not applicable. cium/calmodulin [7] . In sedimentation F-actinbinding assays, half-maximum displacement of 20 pM UTR261 from 10 pM F-actin occurred at 50 pM calcium/calmodulin [7] , whereas in the absence of calcium UTR261 was not displaced from F-actin even at a 10-fold molar excess of calmodulin. The dystrophin actin-binding domain, however, was not displaced in a calciumdependent manner [6, 7] . These findings have important implications for the organization and regulation of dystrophin and utrophin within the cytoskeleton of muscle cells. T h e finding that dystrophin binds to non-muscle actin with approx. fourfold higher affinity than to skeletal muscle actin suggests that dystrophin actually binds to a cortical network of non-muscle actin within the muscle cell rather than directly to the contractile apparatus, as has previously been suggested. T h e anchoring of dystrophin to a continuous network of non-muscle actin overlying the contractile apparatus is infinitely more appealing and also fits with immunofluorescence data showing a continuous network of dystrophin staining beneath the muscle cell membrane [&lo] . Furthermore, if dystrophin was anchored to the contractile machinery, then gaps in the network would be apparent in relaxed muscles corresponding to the bare zone of the A-band where there are no thin (actin) filaments; this situation does not arise.
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C-terminal domains
T h e increasing collection of motifs and domains that constitute the C-terminal regions of dystrophin and utrophin are predominantly involved in the association of these proteins with components of a group of intracellular, transmembrane and extracellular proteins collectively known as the dystrophin-associated proteins (DAPs). It is via these DAPs that dystrophin and utrophin are anchored at the cell membrane and are effectively linked to the extracellular matrix. The most recent additions to this complex region are the WW and ZZ domains. Protein sequence alignments of these two domains from dystrophin, utrophin and other proteins are shown in Figure 2 . The WW domain [13, 14] T h e ZZ domain [17] , so called by analogy with the previously described WW domain and because of its potential for binding two zinc ions, is a putative zinc finger located within the cysteine-rich region of dystrophin, utrophin, the related 87-kDa acetylcholine receptor-associated protein and other unrelated proteins (Figure 2 ) [17] . The putative zinc finger has the form Cys-)4-Cy~-)4~-Cys-&-Cys, with the zinc ion co-ordinated to the four cysteine residues, as shown schematically in Figure 2 (C). T h e related 87-kDa acetycholine receptor-associated protein, which also has a ZZ domain but with six cysteine residues, may co-ordinate two zinc ions, as shown ( Figure 2C) . Although a specific function for the ZZ domain has yet to be found, it is assumed that the putative zinc finger is involved in protein-protein interactions, in a manner analogous to the cytoskeletal zinc finger-containing protein, zyxin [ 181, and not protein-nucleic acid interactions. Zyxin contains three copies of the LIM (C. efeguns Lin-11, rat Isl-1, C. Efeguns Mec-3) zinc finger domain, which are involved in the association of zyxin with ct-actinin and cysteine-rich protein. The ZZ domain is equivalent to (although clearly distinct from) one half of a single LIM domain, with a complete LIM 
Conclusions
It is clear that dystrophin and utrophin form a link between the actin cystoskeleton and the cell membrane and via the membrane-anchored dys- The main connection between the contractile apparatus and the extracellular matrix may be formed by the dystroglycan complex. This complex is composed of 156 kDa DAG (a-dystroglycan), which is located at the extracellular site of the sarcolemma and which binds laminin-2 (merosin), a major component of the extracellular matrix [27] , and 43 kDa DAG (P-dystroglycan), a transmembrane glycoprotein that binds on one side to a-dystroglycan and on the cytoplasmic side of the sarcolemma to the cysteine-rich domain of dystrophin [27, 28] . As such, dystrophin may act as one link of a lattice connecting the extracellular matrix to the sarcomeres. These two proteins of the dystroglycan complex are expressed ubiquitously in several tissues and are transcribed from a single gene [29, 30] . It has been suggested that the dystroglycan complex not only has a mechanical role in muscle but may also be involved in signal transduction via interaction with the adapter protein Grb2 [31-331. Protein studies have shown that a lack of or vast reduction in dystrophin in DMD muscle leads to a secondary loss of DAG expression at the muscle sarcolemma [34] . This loss of DAG is supposed to be a pathogenic factor ultimately leading to muscle necrosis by further disruption of the connection of sarcomeres to the extracellular matrix [ 121. However, DMD patients with large in-frame deletions of the dystrophin gene and preserved expression of the dystroglycan-binding dystrophin domain are not less affected clinically than those lacking dystro-
